Furthermore, other downregulated miRNAs in CR1, such as miR-15b [84], miR-27a [85], miR-29c [86], miR-106a [87] and miR-181a [88], have been described as being implicated in AML pathogenesis or drug resistance. The gene discussed is CR1; the disease is acute myeloid leukemia.